These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8428698)

  • 1. Prognostic significance of DNA content and nuclear morphology in borderline ovarian tumors.
    Drescher CW; Flint A; Hopkins MP; Roberts JA
    Gynecol Oncol; 1993 Feb; 48(2):242-6. PubMed ID: 8428698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear deoxyribonucleic acid heterogeneity of ovarian borderline malignant serous tumors.
    Fu YS; Ro J; Reagan JW; Hall TL; Berek J
    Obstet Gynecol; 1986 Apr; 67(4):478-82. PubMed ID: 3960418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of DNA flow cytometry in borderline malignant ovarian tumors.
    Lai CH; Hsueh S; Chang TC; Tseng CJ; Huang KG; Chou HH; Chen SM
    Cancer; 1996 Aug; 78(4):794-802. PubMed ID: 8756374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of DNA ploidy status in patients with rectal cancer.
    Berczi C; Bocsi J; Bartha I; Math J; Balazs G
    Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA ploidy and nuclear morphometry in adult intracranial ependymomas.
    Onguru O; Ulutin C; Celasun B; Gunhan O
    Clin Neuropathol; 2003; 22(6):266-72. PubMed ID: 14672504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A quantitative study on nuclear DNA content and morphological parameters in ovarian cystadenocarcinoma].
    Liu C; Zhao Y; Sun X
    Zhonghua Fu Chan Ke Za Zhi; 1995 Dec; 30(12):738-40. PubMed ID: 8728920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computerized image analysis and flow cytometric evaluation of ovarian borderline tumors: a study of 24 cases.
    Esposito MJ; Fuchs A
    Cytometry; 1994 Dec; 18(4):218-22. PubMed ID: 7895528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of nuclear DNA quantification and cyclin A expression in epithelial ovarian carcinoma.
    Yoon BS; Kim YT; Kim S; Lee CS; Kim JW; Kim JH; Kim SW; Cho NH
    Eur J Obstet Gynecol Reprod Biol; 2008 Jan; 136(1):110-5. PubMed ID: 17157431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nuclear DNA assay in gynecologic malignant tumors and its clinical significance].
    Cheng X
    Zhonghua Zhong Liu Za Zhi; 1991 Sep; 13(5):353-5. PubMed ID: 1782848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
    Meyer JS; Gersell DJ; Yim S
    Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphometric analysis of nuclear features, ploidy status, and staging in rectal carcinoma.
    Carter CD; Weeks SC; Jarvis LR; Whitehead R
    J Pathol; 1989 Oct; 159(2):113-20. PubMed ID: 2809888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of genomic changes in a large series of malignant ovarian germ cell tumors--relation to clinicopathologic variables.
    Kildal W; Kaern J; Kraggerud SM; Abeler VM; Sudbø J; Tropè CG; Lothe RA; Danielsen HE
    Cancer Genet Cytogenet; 2004 Nov; 155(1):25-32. PubMed ID: 15527899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear characterization and G2M ploidy in human brain tumors using semiautomated image analysis.
    Yoshii Y; Saito A; Tsuboi K; Tsurushima H; Komatsu Y; Tomono Y; Hyodo A; Nose T
    Noshuyo Byori; 1995 Mar; 12(1):61-7. PubMed ID: 7795731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of nuclear DNA content in serous ovarian tumors.
    Erhardt K; Auer G; Björkholm E; Forsslund G; Moberger B; Sifverswärd C; Wicksell G; Zetterberg A
    Cancer Res; 1984 May; 44(5):2198-202. PubMed ID: 6713406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
    Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
    Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometry as a prognostic indicator in women with borderline epithelial ovarian tumors.
    Harlow BL; Fuhr JE; McDonald TW; Schwartz SM; Beuerlein FJ; Weiss NS
    Gynecol Oncol; 1993 Sep; 50(3):305-9. PubMed ID: 8406192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic significance of cellular DNA content and AgNOR count in ovarian cystadenoma].
    Lu XL; Yi WM; Wang LF
    Ai Zheng; 2003 Jan; 22(1):62-5. PubMed ID: 12561439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear DNA content and nuclear atypia. Relation to survival in patients with breast adenocarcinoma and serious ovarian tumors.
    Erhardt K; Silfverswärd C; Auer G
    Anticancer Res; 1989; 9(5):1325-30. PubMed ID: 2589823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.